Motives for initiation, temporary discontinuation, and permanent discontinuation of hormone replacement therapy use among Norwegian women

Maturitas

Volumn 64, Issue 1, 2009, Pages 33-37

  Øren, Anita ^a  

^a SINTEF TECHNOLOGY AND SOCIETY   (Norway)

Author keywords

Attitude; Discontinuation; Hormone replacement therapy; Initiation; Menopause; Motives; Usage patterns

Indexed keywords

SEX HORMONE;

ADULT; ANXIETY; ARTICLE; CLIMACTERIUM; FEMALE; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; NORWAY; PATIENT ATTITUDE; PROPHYLAXIS; QUALITY OF LIFE; QUESTIONNAIRE; UNSPECIFIED SIDE EFFECT;

CLIMACTERIC; DATA COLLECTION; ESTROGEN REPLACEMENT THERAPY; FEMALE; HOT FLASHES; HUMANS; MIDDLE AGED; MOTIVATION; MULTIVARIATE ANALYSIS; NORWAY; PATIENT ACCEPTANCE OF HEALTH CARE; QUALITY OF LIFE; QUESTIONNAIRES; SWEATING;

EID: 69349087887     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2009.07.010     Document Type: Article

References (31)

1. Stearns V., Ullmer L., Lopez J.F., Smith Y., Isaacs C., and Hayes D.F. Hot flushes. The Lancet 360 December (9348) (2002) 1851-1861
2. Castelo-Branco C., and Rostro F. Management of menopause. Minerva Ginecol 58 2 (2006) 137-152
3. Maartens L.W., Leusink G.L., Knottnerus J.A., Smeets C.G., and Pop V.J. Climacteric complaints in the community. Fam Pract 18 April (2) (2001) 189-194
4. Hulley S., Grady D., Bush T., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 280 August (7) (1998) 605-613
5. Grady D., Herrington D., Bittner V., et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 288 July (1) (2002) 49-57
6. Rossouw J.E., Anderson G.L., Prentice R.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288 July (3) (2002) 321-333
7. Rossouw J.E., Prentice R.L., Manson J.E., et al. Postmenopausal Hormone Therapy and Risk of Cardiovascular Disease by Age and Years Since Menopause. JAMA 297 April (13) (2007) 1465-1477
8. Norwegian Institute of Public Health, the department of Pharmacoepidemiology. Drug Consumption in Norway 2002-2007. Oslo, Norway: Norwegian Institute of Public Health; 2009.
9. Du Y., Dören M., Melchert H.U., Scheidt-Nave C., and Knopf H. Differences in menopausal hormone therapy use among women in Germany between 1998 and 2003. BMC Womens Health 7 (2007) 19
10. Hoffmann M., Hammar M., Kjellgren K.I., Lindh-Astrand L., and Brynhildsen J. Changes in women's attitudes towards and use of hormone therapy after HERS and WHI. Maturitas 52 September (1) (2005) 11-17
11. Buist D.S., Newton K.M., Miglioretti D.L., et al. Hormone therapy prescribing patterns in the United States. Obstet Gynecol 104 5 Pt 1 (2004) 1042-1050
12. Kim N., Gross C., Curtis J., et al. The impact of clinical trials on the use of hormone replacement therapy. A population-based study. J Gen Intern Med 20 11 (2005) 1026-1031
13. Løkkegaard E., Lidegaard O., Møller L.N., Agger C., Andreasen A.H., and Jørgensen T. Hormone replacement therapy in Denmark, 1995-2004. Acta Obstet Gynecol Scand 86 11 (2007) 1342-1351
14. Norstat. - the leading data collector in the Nordic region. Available from: http://www.norstat.no.
15. Bakken K., Eggen A.E., and Lund E. Hormone replacement therapy in Norwegian women, 1996-1997. Maturitas 40 November (2) (2001) 131-141
16. Hallquist A.C., Moen M.H., Andrew M., and Aursnes I. [Attitudes to estrogen replacement therapy among Norwegian women]. Tidsskr Nor Lægeforen 126 April (9) (2006) 1195-1197
17. Dahle E.J., Lydersen S., and Moen M.H. Bruk av østrogen og alternativ behandling blant norske kvinner 50-69 år. Tidsskr Nor Lægeforen 126 January (3) (2006) 318-320
18. Du Y., Melchert H.U., and Schäfer-Korting M. Hormone replacement therapy in Germany: Determinants and possible health-related outcomes Results of National Health Surveys from 1984 to 1999. Maturitas 52 July (3-4) (2005) 223-234
19. Parente L., Uyehara C., Larsen W., Whitcomb B., and Farley J. Long-term impact of the women's health initiative on HRT. Arch Gynecol Obstet 277 3 (2008) 219-224
20. Moen M.H., Nilsen S.T., and Iversen O.E. A significant change in Norwegian gynecologist's attitude to hormone therapy is observed after the results of the Women's Health Initiative Study. Acta Obstet Gynecol Scand 84 1 (2005) 92-93
21. Franic D., Verdenik I., Meden-Vrtovec H., and Svab I. Continuation of hormone replacement therapy in Slovenia: a prospective, randomized, controlled trial-1-year follow-up. Maturitas 54 May (2) (2006) 110-118
22. Thunell L., Stadberg E., Milsom I., and Mattsson L.A. Changes in attitudes, knowledge and hormone replacement therapy use: a comparative study in two random samples with 6-year interval. Acta Obstet Gynecol Scand 84 4 (2005) 395-401
23. Castelo-Branco C., Ferrer J., Palacios S., Cornago S., and Peralta S. Spanish post-menopausal women's viewpoints on hormone therapy. Maturitas 56 April (4) (2007) 420-428
24. Bakken K., Eggen A.E., and Lund E. Side-effects of hormone replacement therapy and influence on pattern of use among women aged 45-64 years. The Norwegian Women and Cancer (NOWAC) study 1997. Acta Obstet Gynecol Scand 83 9 (2004) 850-856
25. Rossouw J.E. Postmenopausal hormone therapy for disease prevention: have we learned any lessons from the past?. Clin Pharmacol Ther 83 1 (2008) 14-16
26. Hickey M., Davis S.R., and Sturdee D.W. Treatment of menopausal symptoms: what shall we do now?. Lancet 366 July (9483) (2005) 409-421
27. Rabin D.S., Cipparrone N., Linn E.S., and Moen M. Why menopausal women do not want to take hormone replacement therapy. Menopause 6 1 (1999) 61-67
28. den T.I., and Oddens B.J. Determinants of long-term hormone replacement therapy and reasons for early discontinuation. Obstet Gynecol 95 4 (2000) 507-512
29. Vihtamaki T., Savilahti R., and Tuimala R. Why do postmenopausal women discontinue hormone replacement therapy?. Maturitas 33 October (2) (1999) 99-105
30. Søgaard A.J., Tollan A., Berntsen G.K., Fonnebo V., and Magnus J.H. Hormone replacement therapy: knowledge, attitudes, self-reported use - and sales figures in Nordic women. Maturitas 35 June (3) (2000) 201-214
31. Ekström H., Esseveld J., and Hovelius B. Associations between attitudes toward hormone therapy and current use of it in middle-aged women. Maturitas September (46) 1 (2003) 45-57